Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health
Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market
UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success
UAV Corp Names David Dugas as President and Chief Operating Officer
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology